ANGN - Angion Biomedica EPS misses by $0.60 misses on revenue
Angion Biomedica (ANGN): Q4 GAAP EPS of -$1.90 misses by $0.60.Revenue of $0.46M (-34.3% Y/Y) misses by $1.44M.As of December 31, 2020, Angion had cash and cash equivalents totaling $34.6 million.Press Release
For further details see:
Angion Biomedica EPS misses by $0.60, misses on revenue